Evidence map›Paper›PMID 32301294›Full record

ArticleJournal of Korean medical science2020

The Emerging Crisis of Stakeholders in Implant-based Augmentation Mammaplasty in Korea.

Jae Hong Kim, Nam Sun Paik, Sang Yu Nam, Younghye Cho, Heung Kyu Park

Open access · goldAbstract read
In one paragraph

Article in Journal of Korean medical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jae Hong KimThe W Clinic, Seoul, Korea.ORCID https://orcid.org/0000-0002-7162-9944
Nam Sun PaikDepartment of Surgery, Breast and Thyroid Cancer Center, Ewha Womans University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-2733-2828
Sang Yu NamDepartment of Radiology, Gachon University Gil Medical Center, Incheon, Korea.ORCID https://orcid.org/0000-0003-3078-7206
Younghye ChoDepartment of Pathology, Jangwon Medical Foundation, Seoul, Korea.ORCID https://orcid.org/0000-0001-7208-1899
Heung Kyu ParkDepartment of Surgery, Breast Cancer Center, Gachon University Gil Medical Center, Incheon, Korea. hgjh@gilhospital.com.ORCID https://orcid.org/0000-0002-8284-9221
Gachon University Gil Medical Center · KREwha Womans University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKorea is no longer safe from the risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL); the first reported case was a Korean woman in her 40s who had a 7-year-history of receiving an implant-based augmentation mammaplasty using a textured implant. We conducted this study to discuss the emerging crisis of stakeholders in implant-based augmentation mammaplasty and to propose a multi-disciplinary approach to early detection of its complications.

methodsWe analyzed medical examination data that was collected from patients who visited us between August 12 and September 27, 2019. We evaluated a total of 114 women (n = 114) in the current study. They were evaluated for whether they were in healthy condition. Moreover, their baseline characteristics were also examined; these included age, gender, height (cm), weight (kg), duration since surgery (years), possession of a breast implant card, the site of surgical incision, side of symptoms and reasons for outpatient visit. Furthermore, the patients were also evaluated for their subjective awareness of the manufacturer, surface and shape of the breast implant. Potential complications include malrotation, folding, seroma, capsule thickening, upside-down rotation, rupture, capsule mass and breast mass.

resultsA majority of the patients had a past history of receiving textured implants. The corresponding percentage was 78.95% (90/114) and 85.09% (97/114) based on their subjective awareness of a breast implant and sonographic findings, respectively. That is, it was slightly increased with the use of a breast ultrasound.

conclusionHere, we propose the following approaches. First, patient data should be prospectively collected. By tracking outcomes and complications of an implant-based augmentation mammaplasty, both high-quality care and patient safety can be ensured. Second, stakeholders in implant-based augmentation mammaplasty should collaborate with customers and regulatory authorities. Third, surgeons should consider applying imaging modalities for early detection of postoperative complications.

Indexed as

MammaplastyAdultBreastFemaleHumansLymphoma, Large-Cell, AnaplasticMiddle AgedRepublic of KoreaUltrasonographyYoung AdultBreastBreast ImplantationBreast ImplantsMammaplastySafety

Identifiers

PMID32301294
PMCPMC7167397
OpenAlexW3010151595

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.